Another combination therapy using CDK2 inhibitors with bromodomain-containing protein 4 (BRD4) inhibitors in MYC amplified medulloblastoma resulted in MYC suppression and promoted apoptosis [205]. The gene discussed is BRD4; the disease is medulloblastoma.